Ginsenoside Rb1 Protects Against Diabetic Cardiomyopathy by Regulating the Adipocytokine Pathway

PURPOSE: Obesity and diabetes are often accompanied by chronic inflammation and insulin resistance, which lead to complications such as diabetic cardiomyopathy. Ginsenoside Rb1 has been used to treat diabetes and obesity and reduce inflammation as well as risk of heart diseases. However, the role of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chenyang, Han, Meixin, Zhang, Xuelian, Tong, Hongna, Sun, Xiaobo, Sun, Guibo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743619/
https://www.ncbi.nlm.nih.gov/pubmed/35023944
http://dx.doi.org/10.2147/JIR.S348866

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743619/
https://www.ncbi.nlm.nih.gov/pubmed/35023944
http://dx.doi.org/10.2147/JIR.S348866

Ejemplares similares